ethylnitrosourea has been researched along with Leukemia, Myeloid, Acute in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Maiti, D; Nath, P | 1 |
| Baty, JD; Ding, L; DiPersio, JF; Druley, T; Fulton, RS; Graubert, TA; Heath, S; Hundal, J; Klco, JM; Lamprecht, TL; Ley, TJ; Link, DC; Mardis, ER; Miller, CA; Ramsingh, G; Shen, D; Touma, W; Walter, MJ; Welch, JS; Westervelt, P; Wilson, RK; Wong, TN; Young, AL | 1 |
| Gratzinger, D; Johnson, C; Jonas, BA; Majeti, R | 1 |
| Bartleman, AP; Jacobs, R; Kirkland, JB | 1 |
| Akashi, K; Burel, SA; Harakawa, N; Hetherington, CJ; Iwasaki, H; Lagasse, E; Miyamoto, T; Weissman, IL; Yuan, Y; Zhang, DE; Zhou, L | 1 |
| Nakadate, M; Odashima, S; Ogui, T | 1 |
1 review(s) available for ethylnitrosourea and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
A review of the mutagenic potential of N-ethyl-N-nitrosourea (ENU) to induce hematological malignancies.
Topics: Alkylating Agents; Animals; Carcinogens; Ethylnitrosourea; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Mice; Mutagens; Poly(ADP-ribose) Polymerases; Rats | 2022 |
5 other study(ies) available for ethylnitrosourea and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
Topics: Alleles; Animals; Cell Lineage; Cell Proliferation; Clone Cells; DNA Damage; Drug Resistance, Neoplasm; Ethylnitrosourea; Evolution, Molecular; Genes, p53; Hematopoietic Stem Cells; Heterozygote; Humans; Leukemia, Myeloid, Acute; Mice; Models, Genetic; Mutation | 2015 |
Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity.
Topics: Alkylating Agents; Animals; Bone Marrow Cells; Disease Models, Animal; Ethylnitrosourea; Humans; Leukemia, Myeloid, Acute; Mice; Myelodysplastic Syndromes; Neoplasms, Second Primary; Neoplastic Stem Cells | 2016 |
Niacin supplementation decreases the incidence of alkylation-induced nonlymphocytic leukemia in Long-Evans rats.
Topics: Animals; Anticarcinogenic Agents; Dietary Supplements; Ethylnitrosourea; Incidence; Leukemia, Myeloid, Acute; Male; Neoplasms, Experimental; Niacin; Poly Adenosine Diphosphate Ribose; Random Allocation; Rats; Rats, Long-Evans | 2008 |
AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.
Topics: Animals; Antigens, Differentiation; Base Sequence; Calcium-Binding Proteins; Calgranulin A; Carcinogens; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Core Binding Factor Alpha 2 Subunit; DNA Primers; Ethylnitrosourea; Gene Expression; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Transgenic; Mutation; Oncogene Proteins, Fusion; Promoter Regions, Genetic; RUNX1 Translocation Partner 1 Protein; Transcription Factors; Translocation, Genetic | 2001 |
Rapid and selective induction of erythroleukemia in female Donryu rats by continuous oral administration of 1-ethyl-1-nitrosourea.
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Ear Neoplasms; Ethylnitrosourea; Female; Gastrointestinal Neoplasms; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Mammary Neoplasms, Experimental; Nitrosourea Compounds; Rats | 1976 |